MyEClinic
MyEClinic
Health Dictionary Find a Doctor

Zanamivir overdosage

Zanamivir
RELENZA® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Clinical Studies
Dosage and Administration
Directions for Use
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sophia Saad, Associate Editor – WikiDoc [2]

Overdosage

Overdosage

There have been no reports of overdosage from administration of RELENZA.[1]

References

References

  1. ↑ “http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021036s019lbl.pdf” (PDF). External link in |title= (help)

Adapted from the FDA Package Insert.

Looking for the patient version?

Back to the patient-friendly article

Imprint

Privacy Policy

Terms and Conditions

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH